Loading...
U.S. state
U.S. Imports
$1.3B
U.S. Exports: $0
Deficit of $1.3B (net importer)
Puerto Rico is one of the most export-intensive economies in the US trade system, dominated overwhelmingly by pharmaceutical and biotech products manufactured by major multinational companies operating on the island. The majority of Puerto Rico's exports are pharmaceutical preparations, medical devices, and chemicals destined for the United States mainland, Europe, and Asia. As a US territory, Puerto Rico's trade flows are tracked separately and subject to the Jones Act for maritime shipping with the mainland.
Puerto Rico's exports are dominated by pharmaceutical preparations and medicinal chemicals, which account for the vast majority of export value, along with medical devices and scientific instruments produced by multinational corporations based on the island.
The Jones Act (Merchant Marine Act of 1920) requires that goods shipped between Puerto Rico and the US mainland travel on US-flagged, US-built, and US-crewed vessels, which increases shipping costs and affects the competitiveness of goods moving through this corridor.
The United States mainland is Puerto Rico's dominant trading partner for both exports and imports. Beyond the mainland, key international partners include Belgium, the Netherlands, Germany, and Japan, primarily for pharmaceutical trade flows.
Imports
Exports
| Rank | Product | Import value |
|---|---|---|
| 1 | IMMUNOLOGICAL PRODUCTS, MIXED, NOT IN MSRED DOSES | $245.2M |
| 2 | LT OILS, PREPS GT=70% PETROLEUM/BITUM NT BIODIESEL | $136.7M |
| 3 | SULPHONAMIDES, NESOI | $92.7M |
| 4 | HETEROCYCLIC COMP W NITROGEN HETERO-ATM ONLY NESOI | $75.3M |
| 5 | GENERATING SETS, ELECTRIC, NESOI | $41.0M |
| Rank | Product | Export value |
|---|---|---|
| 1 | IMMUNOLOGICAL PRODUCTS, IN MEASURED DOESE/RTL SALE | $643.8M |
| 2 | MEDICAMENTS NESOI, MEASURED DOSES, RETAIL PK NESOI | $198.2M |
| 3 | OTH ARTIFICAL PTS OF THE BODY & PTS & ACCESSORIES | $48.2M |
| 4 | CMPDS CONT AN UNFUSED PYRIDINE RING ETC NESOI |
| $46.8M |
| 5 | IMMUNOLOGICAL PRODUCTS, MIXED, NOT IN MSRED DOSES | $46.1M |